These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 28727768

  • 1. Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients.
    Rosenzweig B, Rubinstein ND, Reznik E, Shingarev R, Juluru K, Akin O, Hsieh JJ, Jaimes EA, Russo P, Susztak K, Coleman JA, Hakimi AA.
    PLoS One; 2017; 12(7):e0180350. PubMed ID: 28727768
    [Abstract] [Full Text] [Related]

  • 2. Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy.
    Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, Lin L, Li J, Abouassaly R, Campbell SC.
    J Urol; 2020 Jul; 204(1):42-49. PubMed ID: 32073996
    [Abstract] [Full Text] [Related]

  • 3. Histopathological analysis of the non - tumour parenchyma following radical nephrectomy: can it predict renal functional outcome?
    Birendra R, John NT, Duhli N, Devasia A, Kekre N, Manojkumar R.
    Int Braz J Urol; 2017 Jul; 43(4):655-660. PubMed ID: 28379664
    [Abstract] [Full Text] [Related]

  • 4. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
    Sato T, Kawasaki Y, Maekawa M, Takasaki S, Saigusa D, Ota H, Shimada S, Yamashita S, Mitsuzuka K, Yamaguchi H, Ito A, Kinoshita K, Koshiba S, Mano N, Arai Y.
    Int J Cancer; 2019 Jul 15; 145(2):484-493. PubMed ID: 30628065
    [Abstract] [Full Text] [Related]

  • 5. Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens.
    Wang X, Liu Q, Kong W, Huang J, Chen Y, Huang Y, Zhang J.
    BMC Cancer; 2017 Dec 28; 17(1):900. PubMed ID: 29282004
    [Abstract] [Full Text] [Related]

  • 6. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
    Minervini A, Campi R, Di Maida F, Mari A, Montagnani I, Tellini R, Tuccio A, Siena G, Vittori G, Lapini A, Raspollini MR, Carini M.
    Urol Oncol; 2018 Dec 28; 36(12):527.e1-527.e11. PubMed ID: 30268711
    [Abstract] [Full Text] [Related]

  • 7. Two-year analysis for predicting renal function and contralateral hypertrophy after robot-assisted partial nephrectomy: A three-dimensional segmentation technology study.
    Kim DK, Jang Y, Lee J, Hong H, Kim KH, Shin TY, Jung DC, Choi YD, Rha KH.
    Int J Urol; 2015 Dec 28; 22(12):1105-11. PubMed ID: 26332540
    [Abstract] [Full Text] [Related]

  • 8. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma.
    Park BH, Sung HH, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.
    Int Urol Nephrol; 2016 Jun 28; 48(6):977-83. PubMed ID: 26920132
    [Abstract] [Full Text] [Related]

  • 9. Functional Comparison of Renal Tumor Enucleation Versus Standard Partial Nephrectomy.
    Dong W, Gupta GN, Blackwell RH, Wu J, Suk-Ouichai C, Shah A, Capodice SE, Quek ML, Caraballo Antonio E, Aguilar Palacios D, Remer EM, Li J, Zabell J, Isharwal S, Campbell SC.
    Eur Urol Focus; 2017 Oct 28; 3(4-5):437-443. PubMed ID: 28753814
    [Abstract] [Full Text] [Related]

  • 10. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match-Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm.
    Andrade HS, Zargar H, Akca O, Caputo PA, Ramirez D, Kara O, Stein RJ, Chueh SC, Kaouk JH.
    J Endourol; 2016 Apr 28; 30(4):379-83. PubMed ID: 26486995
    [Abstract] [Full Text] [Related]

  • 11. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.
    Eur Urol; 2013 Oct 28; 64(4):600-6. PubMed ID: 23280319
    [Abstract] [Full Text] [Related]

  • 12. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
    Andrade HS, Zargar H, Caputo PA, Akca O, Kara O, Ramirez D, Haber GP, Stein RJ, Kaouk JH.
    Eur Urol; 2016 Jun 28; 69(6):1149-54. PubMed ID: 26719014
    [Abstract] [Full Text] [Related]

  • 13. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
    Rini BI, Plimack ER, Takagi T, Elson P, Wood LS, Dreicer R, Gilligan T, Garcia J, Zhang Z, Kaouk J, Krishnamurthi V, Stephenson AJ, Fergany A, Klein EA, Uzzo RG, Chen DY, Campbell SC.
    J Urol; 2015 Aug 28; 194(2):297-303. PubMed ID: 25813447
    [Abstract] [Full Text] [Related]

  • 14. Histologic Abnormalities in Non-neoplastic Renal Parenchyma and the Risk of Chronic Kidney Disease Following Radical Nephrectomy.
    Brandina R, Moreira Leite KR, Gregório EP, Fernandes KBP, Srougi M.
    Urology; 2017 Feb 28; 100():158-162. PubMed ID: 27725235
    [Abstract] [Full Text] [Related]

  • 15. Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy carried out using the enucleation technique.
    Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K.
    Int J Urol; 2019 Jul 28; 26(7):745-751. PubMed ID: 31001853
    [Abstract] [Full Text] [Related]

  • 16. Differentiating reconstructive techniques in partial nephrectomy: a propensity score analysis.
    Bahler CD, Cary KC, Garg S, DeRoo EM, Tabib CH, Kansal JK, Monn MF, Flack CK, Masterson TA, Sandrasegaran MK, Foster RS, Sundaram CP.
    Can J Urol; 2015 Jun 28; 22(3):7788-96. PubMed ID: 26068626
    [Abstract] [Full Text] [Related]

  • 17. Predictors of Excisional Volume Loss in Partial Nephrectomy: Is There Still Room for Improvement?
    Maurice MJ, Ramirez D, Malkoç E, Kara Ö, Nelson RJ, Caputo PA, Kaouk JH.
    Eur Urol; 2016 Sep 28; 70(3):413-5. PubMed ID: 27217204
    [Abstract] [Full Text] [Related]

  • 18. Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours.
    Ficarra V, Crestani A, Bertolo R, Antonelli A, Longo N, Minervini A, Novara G, Simeone C, Carini M, Mirone V, Porpiglia F, Collaborators.
    BJU Int; 2019 Apr 28; 123(4):639-645. PubMed ID: 30253020
    [Abstract] [Full Text] [Related]

  • 19. A Mathematical Method to Calculate Tumor Contact Surface Area: An Effective Parameter to Predict Renal Function after Partial Nephrectomy.
    Hsieh PF, Wang YD, Huang CP, Wu HC, Yang CR, Chen GH, Chang CH.
    J Urol; 2016 Jul 28; 196(1):33-40. PubMed ID: 26820552
    [Abstract] [Full Text] [Related]

  • 20. Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate.
    Zapala P, Dybowski B, Miazek N, Radziszewski P.
    Int Braz J Urol; 2017 Jul 28; 43(2):209-215. PubMed ID: 28128905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.